Bone metastasis

1 paper1 finding

Humans1

Associations

1

SGLT2 inhibitors

downin humans1HR 0.576

1 study

SGLT2 inhibitors lower the risk of bone metastasis in humans (HR 0.576, 95% CI 0.394-0.843).
Humansin adult women with breast cancer, mastectomy, and type 2 diabetesbone5-year follow-upfemales
SGLT2 inhibitors and risk of distant metastasis in patients with breast cancer and type 2 diabetes: a target trial emulation with biological plausibility analysis
EClinicalMedicine28 Jul 2026

More on SGLT2 inhibitors

Trial sponsors

Novartis Pharmaceuticals Corporation
Company1 trialPhase 4411 people
Third Military Medical University
1 trialPhase 4280 people
Severance Hospital
1 trialPhase 260 people

Latest

1 in 12 months

EClinicalMedicine7 Aug

SGLT2 inhibitors and risk of distant metastasis in patients with breast cancer and type 2 diabetes: a target trial emulation with biological plausibility analysis

Cohort study of 3,569 peopleSGLT2 inhibitors